Erratum: Immunological mechanisms and clinical implications of regulatory T cell deficiency in a systemic autoimmune disorder: Roles of IL-2 versus IL-15 (European Journal of Immunology (2008) vol. 38 (6) 10.1002/eji.200838190);Immunological mechanisms and clinical implications of regulatory T cell deficiency in a systemic autoimmune disorder: Roles of IL-2 versus IL-15

European Journal of Immunology

Volumn 38, Issue 6, 2008, Pages 1664-1676

  Yang, Chui Hong ^a   Tian, Lina ^a,d   Ling, Guang Sheng ^a,c   Trendell Smith, Nigel J ^a   Ma, Liang ^a,c   Lo, Chi Kin ^a   Stott, David I ^b   Liew, Foo Y ^b   Huang, Fang Ping ^a,c  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

^d UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Dendritic cell; IL 15; IL 2; Lupus; Regulatory T cell

Indexed keywords

INTERLEUKIN 2; INTERLEUKIN 5; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 15; INTERLEUKIN 15 RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOIMMUNITY; CELL EXPANSION; CELL FUNCTION; CELL TRANSFER; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; EFFECTOR CELL; FEMALE; IMMUNE RESPONSE; IMMUNOPATHOGENESIS; LYMPHOID ORGAN; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; SUPPRESSOR CELL; SYSTEMIC LUPUS ERYTHEMATOSUS; WILD TYPE; ADOPTIVE TRANSFER; AGE; ANIMAL; ANTIGEN PRESENTING CELL; BLOOD; C57BL MOUSE; CD4+ T LYMPHOCYTE; CELL PROLIFERATION; CYTOLOGY; DRUG EFFECT; IMMUNOLOGY; LYMPH NODE; LYMPHOCYTE ACTIVATION; MALE; METABOLISM; MURPHY ROTHS LARGE LYMPHOPROLIFERATIVE MOUSE; PATHOLOGY; PROTEINURIA; SKIN; SPLEEN; THYMUS; URINE;

ADOPTIVE TRANSFER; AGE FACTORS; ANIMALS; ANTIGEN-PRESENTING CELLS; CD4-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; CYTOKINES; DENDRITIC CELLS; FEMALE; INTERFERON TYPE II; INTERLEUKIN-15; INTERLEUKIN-2; LUPUS ERYTHEMATOSUS, SYSTEMIC; LYMPH NODES; LYMPHOCYTE ACTIVATION; MALE; MICE; MICE, INBRED C57BL; MICE, INBRED MRL LPR; PROTEINURIA; RECEPTORS, INTERLEUKIN-15; SKIN; SPLEEN; T-LYMPHOCYTES, REGULATORY; THYMUS GLAND;

EID: 49649098563     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/eji.200890028     Document Type: Erratum

References (55)

1. Mills, J. A., Systemic lupus erythematosus. N. Engl. J. Med. 1994. 330: 1871-1879.
2. Tough, D. F. and Sprent, J., Turnover of naive- and memory-phenotype T cells. J. Exp. Med. 1994. 179: 1127-1135.
3. Lipsky, P. E., Systemic lupus erythematosus: An autoimmune disease of B cell hyperactivity. Nat. Immunol. 2001. 2: 764-766.
4. Altman, A., Theofilopoulos, A.N., Weiner, R., Katz, D. H. and Dixon, F. J., Analysis of T cell function in autoimmune murine strains. Defects in production and responsiveness to interleukin 2. J. Exp. Med. 1981. 154: 791-808.
5. Huang, F. P. and Stott, D. I., Restoration of an early, progressive defect in responsiveness to T-cell activation in lupus mice by exogenous IL-2. Autoimmunity 1993. 15: 19-29.
6. Manderson, A. P., Botto,M. and Walport, M. J., The role of complement in the development of systemic lupus erythematosus. Annu. Rev. Immunol. 2004. 22: 431-456.
7. Cook, H. T. and Botto, M., Mechanisms of disease: The complement system and the pathogenesis of systemic lupus erythematosus. Nat. Clin. Pract. Rheumatol. 2006. 2: 330-337.
8. Pickering, M. C., Cook, H. T., Warren, J., Bygrave, A. E., Moss, J., Walport, M. J. and Botto, M., Uncontrolled C3 activation causes membranoproliferative glomerulonephritis in mice deficient in complement factor H. Nat. Genet. 2002. 31: 424-428.
9. Matsumoto, K., Yoshikai, Y., Asano, T., Himeno, K., Iwasaki, A. and Nomoto, K., Defect in negative selection in lpr donor-derived T cells differentiating in non-lpr host thymus. J. Exp. Med. 1991. 173: 127-136.
10. Mok, C. C. and Lau, C. S., Pathogenesis of systemic lupus erythematosus. J. Clin. Pathol. 2003. 56: 481-490.
11. Watanabe-Fukunaga, R., Brannan, C. I., Copeland, N. G., Jenkins, N. A. and Nagata, S., Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 1992. 356: 314-317.
12. + regulatory T cells for immunologic self-tolerance and negative control of immune responses. Annu. Rev. Immunol. 2004. 22: 531-562.
13. Kang, H. K. and Datta, S. K., Regulatory T cells in lupus. Int. Rev. Immunol. 2006. 25: 5-25.
14. Mudd, P. A., Teague, B. N. and Farris, A. D., Regulatory T cells and systemic lupus erythematosus. Scand. J. Immunol. 2006. 64: 211-218.
15. + T cells permits the development of spontaneous lupus-like disease in mice, and can be reversed by induction of mucosal tolerance to histone peptide autoantigen. Lupus 2004. 13: 192-200.
16. Crispin, J. C., Martinez, A. and Alcocer-Varela, J., Quantification of regulatory T cells in patients with systemic lupus erythematosus. J. Autoimmun. 2003. 21: 273-276.
17. Mellor-Pita, S., Citores, M. J., Castejon, R., Tutor-Ureta, P., Yebra-Bango, M., Andreu, J. L. and Vargas, J. A., Decrease of regulatory Tcells in patients with systemic lupus erythematosus. Ann. Rheum. Dis. 2006. 65: 553-554.
18. Alvarado-Sanchez, B., Hernandez-Castro, B., Portales-Perez, D., Baranda, L., Layseca-Espinosa, E., Abud-Mendoza, C., Cubillas-Tejeda, A. C. and Gonzalez-Amaro, R., Regulatory T cells in patients with systemic lupus erythematosus. J. Autoimmun. 2006. 27: 110-118.
19. Sakaguchi, S., Sakaguchi, N., Asano, M., Itoh, M. and Toda, M., Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J. Immunol. 1995. 155: 1151-1164.
20. Saoudi, A., Seddon, B., Fowell, D. and Mason, D., The thymus contains a high frequency of cells that prevent autoimmune diabetes on transfer into prediabetic recipients. J. Exp. Med. 1996. 184: 2393-2398.
21. Asano, M., Toda, M., Sakaguchi, N. and Sakaguchi, S., Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation. J. Exp. Med. 1996. 184: 387-396.
22. + regulatory T cells. Int. Immunol. 2004. 16: 1643-1656.
23. Bacchetta, R., Passerini, L., Gambineri, E., Dai, M., Allan, S. E., Perroni, L., Dagna-Bricarelli, F. et al., Defective regulatory and effector T cell functions in patients with FOXP3 mutations. J. Clin. Invest. 2006. 116: 1713-1722.
24. Hori, S., Nomura, T. and Sakaguchi, S., Control of regulatory T cell development by the transcription factor Foxp3. Science 2003. 299: 1057-1061.
25. + regulatory T cells. Nat. Immunol. 2003. 4: 330-336.
26. + T regulatory cells. Nat. Immunol. 2003. 4: 337-342.
27. Brunkow, M. E., Jeffery, E. W., Hjerrild, K. A., Paeper, B., Clark, L. B., Yasayko, S. A., Wilkinson, J. E. et al., Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse. Nat. Genet. 2001. 27: 68-73.
28. Gambineri, E., Torgerson, T. R. and Ochs, H. D., Immune dysregulation, polyendocrinopathy, enteropathy, and X-linked inheritance (IPEX), a syndrome of systemic autoimmunity caused by mutations of FOXP3, a critical regulator of T-cell homeostasis. Curr. Opin. Rheumatol. 2003. 15: 430-435.
29. + regulatory T cells by peripheral expansion. J. Immunol. 2004. 173: 7259-7268.
30. + regulatory T cells by TGF-beta induction of transcription factor Foxp3. J. Exp. Med. 2003. 198: 1875-1886.
31. - T cells through Foxp3 induction and down-regulation of Smad7. J. Immunol. 2004. 172: 5149-5153.
32. + T cells in peripheral blood of patients with systemic lupus erythematosus. Scand. J. Immunol. 2004. 59: 198-202.
33. Miyara, M., Amoura, Z., Parizot, C., Badoual, C., Dorgham, K., Trad, S., Nochy, D. et al., Global natural regulatory T cell depletion in active systemic lupus erythematosus. J. Immunol. 2005. 175: 8392-8400.
34. + regulatory T cells in vitro: A novel defect of T cell regulation in systemic lupus erythematosus. Arthritis Rheum. 2005. 52: 1180-1184.
35. Theofilopoulos, A. N. and Dixon, F. J., Murine models of systemic lupus erythematosus. Adv. Immunol. 1985. 37: 269-390.
36. Cohen, P. L. and Eisenberg, R. A., Lpr and gld: Single gene models of systemic autoimmunity and lymphoproliferative disease. Annu. Rev. Immunol. 1991. 9: 243-269.
37. Watson, M. L., Rao, J. K., Gilkeson, G. S., Ruiz, P., Eicher, E. M., Pisetsky, D. S., Matsuzawa, A. et al., Genetic analysis of MRL-lpr mice: Relationship of the Fas apoptosis gene to disease manifestations and renal disease-modifying loci. J. Exp. Med. 1992. 176: 1645-1656.
38. Chan, O. T., Paliwal, V., McNiff, J. M., Park, S. H., Bendelac, A. and Shlomchik, M. J., Deficiency in beta(2)-microglobulin, but not CD1, accelerates spontaneous lupus skin disease while inhibiting nephritis in MRL-Fas(lpr) nice: An example of disease regulation at the organ level. J. Immunol. 2001. 167: 2985-2990.
39. Huggins, M. L., Huang, F. P., Xu, D., Lindop, G. and Stott, D. I., Modulation of autoimmune disease in the MRL-lpr/lpr mouse by IL-2 and TGF-beta1 gene therapy using attenuated Salmonella typhimurium as gene carrier. Lupus 1999. 8: 29-38.
40. Ma, L., Chan, K. W., Trendell-Smith, N. J., Wu, A., Tian, L., Lam, A. C., Chan, A. K. et al., Systemic autoimmune disease induced by dendritic cells that have captured necrotic but not apoptotic cells in susceptible mouse strains. Eur. J. Immunol. 2005. 35: 3364-3375.
41. Grabstein, K. H., Eisenman, J., Shanebeck, K., Rauch, C., Srinivasan, S., Fung, V., Beers, C. et al., Cloning of a T cell growth factor that interacts with the beta chain of the interleukin-2 receptor. Science 1994. 264: 965-968.
42. McInnes, I. B., al Mughales, J., Field, M., Leung, B. P., Huang, F. P., Dixon, R., Sturrock, R. D. et al., The role of interleukin-15 in T-cell migration and activation in rheumatoid arthritis. Nat. Med. 1996. 2: 175-182.
43. + T cells that require antigen-specific activation for suppression. J. Immunol. 2003. 171: 6431-6441.
44. + regulatory T cells including suppressors of alloreactivity. Immunol. Rev. 2006. 212: 314-329.
45. Scalapino, K. J., Tang, Q., Bluestone, J. A., Bonyhadi,M. L. and Daikh, D. I., Suppression of disease in New Zealand Black/New Zealand White lupus-prone mice by adoptive transfer of ex vivo expanded regulatory T cells. J. Immunol. 2006. 177: 1451-1459.
46. Ma, A., Koka, R. and Burkett, P., Diverse functions of IL-2, IL-15, and IL-7 in lymphoid homeostasis. Annu. Rev. Immunol. 2006. 24: 657-679.
47. + T cell suppressor function. J. Immunol. 2004. 172: 6519-6523.
48. Ruckert, R., Brandt, K., Bulanova, E., Mirghomizadeh, F., Paus, R. and Bulfone-Paus, S., Dendritic cell-derived IL-15 controls the induction of CD8 T cell immune responses. Eur. J. Immunol. 2003. 33: 3493-3503.
49. Ohteki, T., Tada, H., Ishida, K., Sato, T., Maki, C., Yamada, T., Hamuro, J. and Koyasu, S., Essential roles of DC-derived IL-15 as a mediator of inflammatory responses in vivo. J. Exp. Med. 2006. 203: 2329-2338.
50. + regulatory T cells from peripheral Foxp3 precursors. Blood 2007. 110: 4293-4302.
51. + regulatory T cells by antigen-processing dendritic cells. J. Exp. Med. 2003. 198: 235-247.
52. high regulatory T cells by human dendritic cells (DCs) in vitro and after injection of cytokine-matured DCs in myeloma patients. Blood 2006. 108: 2655-2661.
53. + regulatory cell activation and function by dendritic cells. Int. Immunol. 2004. 16: 1769-1780.
54. Feau, S., Facchinetti, V., Granucci, F., Citterio, S., Jarrossay, D., Seresini, S., Protti, M. P. et al., Dendritic cell-derived IL-2 production is regulated by IL-15 in humans and in mice. Blood 2005. 105: 697-702.
55. Lio, C. W. and Hsieh, C. S., A two-step process for thymic regulatory T cell development. Immunity 2008. 28: 100-111.